JD Supra: Mergers
JUNE 25, 2025
The case arose from Alexion Pharmaceuticals, Inc.’s A recent Delaware Chancery Court opinion offers a significant example of how courts may apply complex probability analysis to determine the amount of damages in an earnout dispute. s 2018 acquisition of Syntimmune, Inc.
MergersCorp M&A International
NOVEMBER 16, 2024
His presidency brought with it a unique set of policies and attitudes that would directly influence the realm of mergers and acquisitions (M&A). These regulatory rollbacks naturally benefitted companies considering mergers and acquisitions. as a favorable destination for investment. Foreign companies sought to acquire U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cooley M&A
JANUARY 22, 2025
While global M&A deal value across sectors remained relatively flat overall , pharmaceuticals and life sciences M&A in 2024 dipped relative to the prior year. Indeed, the largest US biotech exit in 2024 was Vertex Pharmaceuticals $4.9 Immunology deals stood out, including Vertex Pharmaceuticals $4.9 from 2023. [1]
Global Newswire by Notified: M&A
JUNE 23, 2025
NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Dr Ashleys Limited, a Hong Kong based global pharmaceutical company (“Dr Ashleys”), and Impact BioMedical Inc.
JD Supra: Mergers
JUNE 19, 2025
On June 11, 2025, the Delaware Court of Chancery found Alexion Pharmaceuticals liable for more than $180 million in damages to former stockholders of Syntimmune, Inc.,
Global Newswire by Notified: M&A
JUNE 9, 2025
Lightship”] Announce Strategic Merger to Accelerate Scale and Expanded Access in Clinical Research June 09, 2025 09:09 ET | Source: Circuit Clinical Circuit Clinical BUFFALO, N.Y. This merger is more than a business combination; it’s a bold response to the evolving needs of clinical research,” said Dr. Irfan Khan, CEO of Circuit Clinical.
Global Newswire by Notified: M&A
JUNE 24, 2025
Impact”), has entered into a definitive merger agreement (the “Merger Agreement”) with Dr. Ashleys Limited (“Dr. Ashleys”), a global pharmaceutical company.
Expert insights. Personalized for you.
130 
Let's personalize your content